Buy Mirati Therapeutics Stock | MRTX Stock Price & Latest News | Public
MRTX

Mirati Therapeutics

$0.00 (0.00%)Today

    About MRTX

    Mirati Therapeutics, Inc. is a clinical-stage oncology company. The firm engages in developing a pipeline of oncology products to treat genetic, immunological and epigenetic drivers of cancer in subsets of cancer patients. Its clinical pipeline consists of glesatinib, s...Read more

    Buy any stock with any amount of money.

    Download the App
    Download the app

    What Wall Street Thinks

    Events

    List of events that could affect this stock.

    Earnings

    The value each share was expected to gain vs. the value that each share actually gained

    0
    -0.74
    -1.48
    -2.22
    Q1 2020
    Q2 2020
    Q3 2020
    Q4 2020

    Expected EPS
    Q4 2020

    -$2.22

    Actual EPS
    Q4 2020

    Stats

    Market Cap$11,33B
    Volume7,51k
    Price-to-Earnings Ratio
    Dividend Rate
    Dividend Yield
    1 Year High$240.58
    1 Year Low$66.01
    Open$226.67
    High$234.56
    Low$226.67

    Buy any stock with any amount of money.

    Download the App
    Download the app